428698007: Everolimus (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\Everolimus (substance)
\Substance categorized by disposition\Immunomodulator\Immunosuppressant (substance)\Everolimus (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Everolimus (substance)
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Everolimus (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Lactam\Everolimus (substance)

\Organic compound\Substance with ether structure\Everolimus (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Lactam\Everolimus (substance)
\Organic compound\Lactone (substance)\Macrolide (substance)\Everolimus (substance)
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Amide\Lactam\Everolimus (substance)
\Organic compound\Ketone\Cyclic ketone\Everolimus (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Everolimus (substance)	Is a	Macrolide immunosuppressant	false	Inferred relationship	Some
Everolimus (substance)	Is a	Protein kinase inhibitor	true	Inferred relationship	Some
Everolimus (substance)	Is a	Antineoplastic agent (substance)	true	Inferred relationship	Some
Everolimus (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein kinase inhibitor (disposition)	true	Inferred relationship	Some
Everolimus (substance)	Is a	Macrolide (substance)	true	Inferred relationship	Some
Everolimus (substance)	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some
Everolimus (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Some
Everolimus (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Everolimus (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Everolimus (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Everolimus (substance)	Is a	Cyclic ketone	true	Inferred relationship	Some
Everolimus (substance)	Is a	Lactam	true	Inferred relationship	Some
Everolimus (substance)	Is a	éther	false	Inferred relationship	Some
Everolimus (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing everolimus (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 100 microgram/cc drug eluting stent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some
Everolimus 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some
Product containing precisely everolimus 750 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some
Product containing precisely everolimus 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some
Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some
Everolimus 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 500 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 500 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 750 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 750 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 500 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 750 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 250 microgram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing only everolimus (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus therapy	Direct substance	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 100 microgram/cm2 drug eluting stent	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 2.5 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 2.5 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 2 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 2 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 3 milligram/1 each conventional release orodispersible tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 3 milligram/1 each conventional release orodispersible tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 1 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Product containing precisely everolimus 1 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 2 mg dispersible oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 2 mg dispersible oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 3 mg dispersible oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 3 mg dispersible oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 5 mg dispersible oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Everolimus (substance)	Inferred relationship	Some	1
Everolimus 5 mg dispersible oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Everolimus (substance)	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2688393017	Everolimus (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2693517016	Everolimus	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
54451000195112	everolimus	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
189531000077116	everolimus	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
810761000172112	évérolimus	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
68801000195114	Everolimus	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module